PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2028

Conditions
Lymphoma
Interventions
RADIATION

Involved Field Radiotherapy

IFRT 30Gy delivered in daily fractions of 1.8 - 2.0Gy

OTHER

No further treatment

Trial Locations (1)

M20 4BX

Christie Hospital, Manchester

All Listed Sponsors
collaborator

The Christie NHS Foundation Trust

OTHER

lead

University College, London

OTHER